Table 2.
Association between sociodemographic and clinical factors and anemia status among primary care patients with chronic kidney disease and type 2 diabetes mellitus in Muscat, Oman (n=300)
| Factor | Anemia status | P-value | |
|---|---|---|---|
|
| |||
| Present (n=88) N (%) | Absent (n=212) N (%) | ||
| Gender | |||
| Male | 28 (17.9) | 128 (82.1) | <0.001 |
| Female | 60 (41.7) | 84 (58.3) | |
| Age (years) | |||
| 20–35 | 1 (6.7) | 14 (93.3) | 0.134 |
| 36–50 | 36 (29.5) | 86 (70.5) | |
| 51–65 | 51 (31.3) | 112 (68.7) | |
| BMI (kg/m2) | |||
| <18.5 | 1 (100) | 0 | 0.259 |
| 18.5–24.9 | 8 (22.9) | 27 (77.1) | |
| 25–29.9 | 31 (27) | 84 (73.0) | |
| ≥30 | 48 (32.2) | 101 (67.0) | |
| Duration of T2DM (years) | |||
| <3 | 11 (23.4) | 36 (76.6) | 0.404 |
| 3–5 | 16 (35.6) | 29 (64.4) | |
| 5–10 | 38 (32.5) | 79 (67.5) | |
| >10 | 23 (25.3) | 68 (74.7) | |
| Stage of CKD | |||
| Stage 1 | 59 (31.4) | 129 (68.6) | 0.266 |
| Stage 2 | 25 (24.3) | 78 (75.7) | |
| Stage 3 | 4 (44.4) | 5 (55.6) | |
| Stage 4 | 0 | 0 | |
| Stage 5 | 0 | 0 | |
| ACR | |||
| Normal | 63 (31.5) | 137 (68.5) | 0.528 |
| Abnormal | 23 (27.7) | 60 (72.3) | |
| Hypertension | |||
| Yes | 45 (32.1) | 95 (67.9) | 0.317 |
| No | 43 (26.9) | 117 (73.1) | |
| Taking ACEIs | |||
| Yes | 32 (26.9) | 87 (73.1) | 0.451 |
| No | 56 (30.9) | 125 (69.1) | |
BMI=Body mass index, T2DM=Type 2 diabetes mellitus, CKD=Chronic kidney disease, ACR=Albumin-to-creatinine ratio, ACEIs=Angiotensin-converting enzyme inhibitors